Asthma is an inflammatory disease of the lungs. It makes breathing difficult and brings on attacks of coughing, wheezing, tightness in the chest and shortness of breath.
The exact cause of asthma is not known; it is suspected to be due to genetic and/or environmental factors. Most commonly observed symptoms include shortness of breath, wheezing, coughing and tightness in the chest. Asthma can be controlled with medications.
A multicenter, randomized, parallel-group, placebo-controlled, 4-week clinical endpoint bioequivalence study comparing fluticasone propionate/salmeterol 100/50 μg inhalation powder (Cipla Ltd., India) with Advair® Diskus 100/50 μg (GlaxoSmithKline, USA) in Asthma patients.
SPONSOR: Cipla Ltd., India
STATUS: Open, enrolling now...!
TRIAL PERIOD: 5 WEEKS.
ENROLLED: 65 SUBJECTS.
RANDOMIZED: 37 SUBJECTS.